InGeneron

About:

InGeneron enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells.

Website: http://www.ingeneron.com/

Twitter/X: InGeneronInc

Top Investors: Sanford Health

Description:

InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Its system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells. Founded in 2006, we are a Houston-headquartered, privately held company that was formed to innovate cell-based technologies for health care and life science research. The work of our scientists and doctors in the field of the stem and regenerative cell research has enabled us to develop a regenerative cell therapy product platform for multiple potential applications. This work has yielded numerous peer-reviewed publications and studies on the use of autologous adult stem cells – those that are extracted from and reintroduced into the same person – to promote healing.

Total Funding Amount:

$52.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2006-01-01

Contact Email:

contact(AT)ingeneron.com

Founders:

Eckhard Alt

Number of Employees:

11-50

Last Funding Date:

2024-03-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai